HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarfaraz Hasni Selected Research

Chronic Renal Insufficiency

1/2019Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sarfaraz Hasni Research Topics

Disease

19Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2023 - 11/2013
6Autoimmune Diseases (Autoimmune Disease)
03/2024 - 01/2017
4Inflammation (Inflammations)
01/2020 - 10/2014
3Proteinuria
02/2024 - 01/2019
3Infections
08/2023 - 03/2017
3Rheumatoid Arthritis
01/2017 - 01/2016
2Sialadenitis
03/2024 - 08/2023
2Vascular Diseases (Vascular Disease)
02/2024 - 01/2018
2COVID-19
10/2023 - 11/2020
2Rheumatic Diseases (Rheumatism)
12/2022 - 01/2016
2Insulin Resistance
08/2022 - 01/2019
2Necrosis
01/2019 - 01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
02/2024
1Disease Progression
10/2023
1Pneumonia (Pneumonitis)
08/2023
1Lupus Nephritis
08/2023
1Kidney Diseases (Kidney Disease)
08/2023
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2023
1Amenorrhea
12/2022
1Hypertension (High Blood Pressure)
12/2022
1Primary Ovarian Insufficiency
12/2022
1Psychotic Disorders (Schizoaffective Disorder)
01/2021
1Job Syndrome (Hyper-IgE Syndrome)
01/2021
1Delirium
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2020
1Atherosclerosis
01/2020
1Acute Coronary Syndrome
01/2020
1Vascular System Injuries
01/2020
1Chronic Renal Insufficiency
01/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Oral Manifestations
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Neutropenia
04/2017
1Opportunistic Infections (Opportunistic Infection)
03/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017
1Sarcopenia
01/2017
1Communicable Diseases (Infectious Diseases)
01/2016
1Genetic Translocation (Chromosomal Translocation)
10/2014
1Nephritis
01/2014

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
02/2024 - 11/2013
5AutoantibodiesIBA
11/2020 - 01/2014
4InterferonsIBA
03/2024 - 01/2016
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2023 - 03/2017
3AntibodiesIBA
01/2021 - 01/2018
3Immunoglobulin E (IgE)IBA
01/2019 - 01/2014
2Janus Kinase InhibitorsIBA
03/2024 - 08/2023
2Antigen-Antibody Complex (Immune Complex)IBA
02/2024 - 01/2020
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
10/2023 - 10/2021
2Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2019
2Lipoproteins (Lipoprotein)IBA
08/2022 - 01/2019
2Interferon Type IIBA
11/2020 - 10/2020
2Estrogens (Estrogen)FDA Link
12/2019 - 12/2019
1itaconic acidIBA
02/2024
1aconitate decarboxylaseIBA
02/2024
1TriazolesIBA
08/2023
1EchinocandinsIBA
08/2023
1posaconazoleFDA Link
08/2023
1Inosine Triphosphate (ITP)IBA
04/2023
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2022
1Estradiol (Delestrogen)FDA LinkGeneric
12/2022
1Follicle Stimulating Hormone (Follitropin)FDA Link
12/2022
1Anti-Mullerian HormoneIBA
12/2022
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2022
1Pioglitazone (Actos)FDA Link
08/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Antinuclear AntibodiesIBA
01/2021
1Interferon-alpha (Interferon Alfa)IBA
11/2020
1ProteomeIBA
10/2020
1Oxidized LDL ReceptorsIBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1oxidized low density lipoproteinIBA
01/2020
1Lymphotoxin-alpha (Lymphotoxin)IBA
01/2019
1anti-IgE antibodiesIBA
01/2019
1Prednisone (Sone)FDA LinkGeneric
01/2019
1CreatinineIBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Omalizumab (Xolair)FDA Link
01/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1Ubiquitinated ProteinsIBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1UbiquitinIBA
01/2018
1SteroidsIBA
03/2017
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
03/2017
1Azathioprine (Imuran)FDA LinkGeneric
03/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1EpitopesIBA
01/2017
1tofacitinibIBA
01/2017
1Janus KinasesIBA
01/2017
1HDL LipoproteinsIBA
09/2014
1EnzymesIBA
09/2014

Therapy/Procedure

4Therapeutics
03/2024 - 12/2022
1Aftercare (After-Treatment)
12/2022
1Cell Transplantation
01/2022
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2019
1Physical Therapy Modalities (Physical Therapy Technique)
01/2017